Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

BACKGROUND: The outbreak of Coronavirus Disease 2019 (COVID-19) has been increasing rapidly. This disease causes an increase in proinflammatory cytokine production that leads to cytokine storm or cytokine release syndrome (CRS). Autologous activated platelet-rich plasma (aaPRP) contains various type...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Inflam
Main Authors: Karina, Karina, Rosliana, Iis, Rosadi, Imam, Sobariah, Siti, Christoffel, Louis Martin, Novariani, Rita, Rosidah, Siti, Fatkhurohman, Novy, Hertati, Yuli, Puspitaningrum, Nurlaela, Subroto, Wismo Reja, Afini, Irsyah, Ernanda, Difky
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285191/
https://ncbi.nlm.nih.gov/pubmed/34306612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5531873
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados